AzTrials
AzTrials

The Effective Factors on the Grief Reactions to the Death InformationNCT04385628

Breaking the Bad News to the Bereaved Family and Their Reactions

An observational study of The Effective Factors on the Grief Reactions to the Death Information, run by Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey at 1 site in Turkey (Türkiye).

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The demographic characteristics, satisfaction survey evaluations and emotional reactions of the relatives of the patients who are admitted to the intensive care unit and who have an expected mortality rate higher than 50% according to the Apache-2 scoring system will be investigated. Read more about this study

Who is it for?
Any ageHealthy volunteers can take part
What is being tested?
the patient' relatives satisfaction questionnaire
How many people
100 participants
Where
1 siteTurkey (Türkiye)
Study dates
25 Apr 2019to 30 Nov 2020
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Study population: Relatives of patients hospitalized in intensive care unit

Who may be able to join

  • Apache 2 score> 25 or Expected death rate> 50%,
  • Hospitalization period> 72 hours in intensive care unit -

Who cannot join

  • Apache 2 score <25 or Expected death rate <50%,
  • Those who have a stay in ICU <72 hours
  • Currently receiving psychological medication
  • Those who do not accept one of the legal heirs to participate in the study

Trial locations and contacts

1 site in 1 country.

bülent barış güven contact

05336383445

barguv@gmail.com

selçuk Taşçı contact

05359715480

drselcukdasci@hotmail.com

Turkey (Türkiye)1 site, 1 recruiting
  • Sultan 2.Abdulhamidhan training hospital

    Istanbul, 34668

    Bülent B güven, 05336383445, barguv@gmail.com

    Recruiting

Other trials in Turkey (Türkiye)

About this study

Official title: The Factors Affecting the Emotional Reactions of Relatives of Intensive Care Patients to the News of Death.

The demographic characteristics, satisfaction survey evaluations and emotional reactions of the relatives of the patients who are admitted to the intensive care unit and who have an expected mortality rate higher than 50% according to the Apache-2 scoring system will be investigated.

Read the detailed description

Patients with an APACHE-2 score> 25 (Expected mortality rate> 50%) during the first 24 hours of hospitalization in the Intensive Care Unit will be included in the study. A person who comes to the most frequent visit from relatives of patients will be included in the study. Demographic data of the relative of the patient after the informed volunteer consent form has been approved (age, proximity, educational background, patient co-existence, ethnicity, marital status, number of children, history of psychological treatment and the presence of an intensive care treatment history of any family member before) will be registered. After the 3rd, 10th, and 30th days of patient admission, and once a month, the patient satisfaction survey will be filled face to face during informing the patient's relative. In this patient group with an expected mortality of> 50%, if death occurs, the information will be made to the visitor of the patient who frequently visits the patient and agrees to participate in the study. The emotional reaction of the relative of the patient participating in the study during the declaration of death will be recorded in the case report form.

Grief reaction is unique, and it will differ from one individual to another. Possible reactions of relatives of patients during the death notification (Emotional Reactions)

  1. Regular response; In this case, the relatives of the patients often describe the event as expected or my patient is now free from suffering.
  2. Initial shock reaction; It may be complete desperation and a state of closure,
  3. Denial- This is an initial defense mechanism after the unexpected, devastating news, and it should be recognized and tolerated. Acceptance may be possible by encouraging the relatives to view the body of the deceased, especially to those relatives who were not present at the time of death
  4. Anger- This is a common reaction after the sudden death of a beloved relative. The expression of this anger can vary from mild irritation to violent behavior. This can be expressed on self, hospital staff, or any other person. Anger will gradually diminish once expressed
  5. Guilt- This is nothing but the inward expression of anger and self-blame. Consoling words of the health care team will help to do away with this emotion.
Being tested
the patient' relatives satisfaction questionnaire
Keywords
patient death , grief reactions

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • the patient' relatives satisfaction questionnaireBehavioural

    The patient' relatives satisfaction questionnaire will be filled face to face during informing the patient's relatives after the 3rd, 10th, and 30th days of patient admission, and once a month. We will evaluate the most recent questionnaire.

Study groups in NCT04385628
Study groupRoleWhat they receive
Relatives of patients hospitalized in the intensive care unitDemographic data of the relative of the patient (age, proximity, educational background, patient co-existence, ethnicity, marital status, number of children, history of psychological treatment and the presence of an intensive care treatment history of any family member before) will be recorded. After the 3rd, 10th, and 30th days of patient admission, and once a month, the patient satisfaction survey will be filled face to face during informing the patient's relative. These three main data (Demographic data of the patient relatives, the most recent satisfaction questionnaire and emotional reactions observed while reporting death) will be evaluated and interpreted.
Receives: Behavioral: the patient' relatives satisfaction questionnaire

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Regular response to the bad news

    These three main data (Demographic data of the patient relatives, the most recent satisfaction questionnaire and emotional reactions observed while reporting death) will be evaluated and interpreted.

    Measured: From admission to discharge, up to 3 month

  2. Initial shock reactions to the bad news

    These three main data (Demographic data of the patient relatives, the most recent

    Measured: From admission to discharge, up to 3 month

  3. Denial to the bad news

    These three main data (Demographic data of the patient relatives, the most recent

    Measured: From admission to discharge, up to 3 month

  4. Anger to the bad news

    These three main data (Demographic data of the patient relatives, the most recent

    Measured: From admission to discharge, up to 3 month

  5. Guilt to the bad news

    These three main data (Demographic data of the patient relatives, the most recent

    Measured: From admission to discharge, up to 3 month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 May 2020
  2. Study start25 Apr 2019
  3. Primary completion29 Sep 2020 (estimated)
  4. Study completion30 Nov 2020 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Family based
Time perspective
Prospective
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04385628
Sponsor's protocol ID
48670771-514.10
Status last verified
May 2020
First submitted
9 May 2020
Last updated
13 May 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Naik SB. Death in the hospital: Breaking the bad news to the bereaved family. Indian J Crit Care Med. 2013 May;17(3):178-81. doi: 10.4103/0972-5229.117067.

    PubMed 24082616
  • Jurkovich GJ, Pierce B, Pananen L, Rivara FP. Giving bad news: the family perspective. J Trauma. 2000 May;48(5):865-70; discussion 870-3. doi: 10.1097/00005373-200005000-00009.

    PubMed 10823529

Questions about this trial

What is this clinical trial studying?

An observational study of The Effective Factors on the Grief Reactions to the Death Information, run by Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 13 May 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact bülent barış güven (05336383445, barguv@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Regular response to the bad news (time frame: From admission to discharge, up to 3 month). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04385628, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 May 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in